Table 14 IC50 values of the synthesized compounds (20a-j) against C6 and HepG2 cancer cell line Yurttas et al. [35]
From: Synthesis and therapeutic potential of imidazole containing compounds
Compounds | IC50 value | |
|---|---|---|
C6 | HepG2 | |
20a | 27.0 ± 1.41 | 50.0 ± 5.0 |
20b | 20 ± 2.0 | 26.33 ± 1.53 |
20c | 32.67 ± 6.43 | 275.0 ± 35.36 |
20d | 22.0 ± 3.61 | 29.33 ± 1.15 |
20e | 16.33 ± 2.31 | 31.67 ± 7.23 |
20f | 19.50 ± 2.12 | 28.67 ± 1.15 |
20g | 15.67 ± 2.52 | 58.33 ± 2.89 |
20h |  > 500 |  > 500 |
20i | 24.33 ± 4.04 |  > 500 |
20j | 19.33 ± 2.31 |  > 500 |
Cisplatin | 23.0 ± 1.73 | 46.67 ± 7.64 |